Referências
bibliográficas
·
Agarwal SK.
Biologic agents in rheumatoid arthritis: an update for managed care
professionals. J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl B):S14-8.
·
Farheen K,
Agarwal SK. Assessment of disease activity and treatment outcomes in
rheumatoid arthritis. J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl
B):S09-13.
·
M M, H G, S
H, A J, Khan W. The future of rheumatoid arthritis and hand surgery -
combining evolutionary pharmacology and surgical technique. Open Orthop J.
2012;6:88-94.
·
Fauci AS,
Braunwald E, Kasper D, Hauser S. Harrison's Manual of Medicine:
McGraw-Hill Medical; 2009.
·
Reis C. Aspectos Parcelares da Epidemiologia da
Artrite Reumatóide. Lisboa FCUL. 2011.
·
Carrilho, F. (2009). Influência de níveis de
vitamina D na actividade da artrite reumatóide. Coimbra, Faculdade de
Medicina da Universidade de Coimbra. Mestrado
129.
·
Mercado FB
MR, Klestov AC, Bartold PM. Relationship between rheumatoid arthritis and
periodontitis. Journal of Periodontology. 2001.
·
Filippin
LI, Vercelino R, Marroni NP, Xavier RM. Influência
de processos redox na resposta inflamatória da artrite reumatóide. Revista Brasileira de Reumatologia. 2008;48:17-24.
·
Agarwal,
S.K., Core management principles in rheumatoid arthritis to help guide
managed care professionals. J Manag Care Pharm, 2011. 17(9 Suppl B): p.
S03-8.
·
Mies
Richie, A. and M.L. Francis, Diagnostic approach to polyarticular joint
pain. Am Fam Physician, 2003. 68(6): p. 1151-60.
·
Sokka, T., Radiographic
scoring in rheumatoid arthritis: a short introduction to the methods. Bull
NYU Hosp Jt Dis, 2008. 66(2): p. 166-8.
·
Tavares
Junior, W.C., R. Rolim, and A.M. Kakehasi, Magnetic resonance imaging in
rheumatoid arthritis. Rev Bras Reumatol, 2011. 51(6): p. 635-41.
·
Jain, M.
and J. Samuels, Musculoskeletal ultrasound as a diagnostic and prognostic
tool in rheumatoid arthritis. Bull NYU Hosp Jt Dis, 2011. 69(3): p. 215-9.
·
Nishimura,
K., et al., Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated
peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern
Med, 2007. 146(11): p. 797-808.
·
Lehninger,
A.L., D.L. Nelson, and M.M. Cox, Principles of Biochemistry: Advance
Chapters from the 2000 Edition1999: Worth Publishers.
·
Scott,
D.L., Prognostic factors in early rheumatoid arthritis. Rheumatology
(Oxford), 2000. 39 Suppl 1: p. 24-9
·
Vencovsky,
J., et al., Autoantibodies can be prognostic markers of an erosive disease
in early rheumatoid arthritis. Ann Rheum Dis, 2003. 62(5): p. 427-30.
·
Miller, A.,
M. Green, and D. Robinson, Simple rule for calculating normal erythrocyte
sedimentation rate. Br Med J (Clin Res Ed), 1983. 286(6361): p. 266.
·
Gumpel JM.
Rheumatoid arthritis. Br Med J. 1978 Oct 14;2(6144):1068-70.
·
Vieira-Sousa E, Gerlag DM, Tak PP. Synovial tissue response to treatment in rheumatoid
arthritis. Open Rheumatol J. 2011;5:115-22.
·
Nanke Y,
Yago T, Kotake S. The effects of disease modifying anti-rheumatic drugs on
osteoclastogenesis and bone destruction in rheumatoid arthritis. Nihon Rinsho
Meneki Gakkai Kaishi. 2011;34(6):493-500.
·
Yazici Y,
Regens AL. Promising new treatments for rheumatoid arthritis - the kinase
inhibitors. Bull NYU Hosp Jt Dis. 2011;69(3):233-7.
·
Knijff-Dutmer,
E., et al., Rheumatoid factor measured by fluoroimmunoassay: a responsive
measure of rheumatoid arthritis disease activity that is associated with joint
damage. Ann Rheum Dis, 2002. 61(7): p. 603-7.
Nenhum comentário:
Postar um comentário